A UAE-led study, the ‘Suite Ride’ project, tested diabetes tools like continuous glucose monitors (CGMs) and insulin pens aboard the International Space Station, showing they work effectively in microgravity. This breakthrough, announced in New York’s Times Square and at the Burjeel Institute for Global Health, could allow the first astronaut with diabetes to participate in space missions. The research not only advances space exploration but also promotes inclusivity in STEM and space careers. What do you think—could this open doors for more people with medical conditions to pursue space travel?
Add your Comment: